Description
Cinnarizine is a medication used primarily for motion sickness, vertigo, and other vestibular disorders (i.e., dizziness, inner ear balance problems). It acts as an antihistamine combined with a calcium-channel blocker, reducing vestibular responses and improving blood flow in the inner ear. 

Prescription
Yes — this is a prescription medicine in most countries (requires a doctor’s prescription). 

Therapeutic Category
Antihistamine / vestibular suppressant / calcium-channel blocker used for motion sickness and inner ear balance disorders. 

Active Ingredients / Composition

• Active: Cinnarizine 25 mg per tablet.
• Excipients vary by manufacturer (tablet binders, fillers) — check local pack for full list.

Variant
Tablet form, 25 mg strength (some markets may also have other strengths like 15 mg, 30 mg). 

Consume Type
Oral — swallow the tablet with water (some sources say tablets can be sucked/chewed, but follow your prescription). 

Directions / Usage

• For motion sickness: Adults and children age ≥12 years: typically take 25 mg (1 tablet) 2 hours before travel, then one tablet every 8 hours during travel if needed. 
• For vertigo / inner ear disorders: Adults: 25 mg three times daily (after meals) until symptoms improve.
  Tablets should preferably be taken after meals to reduce stomach upset. 
• Always follow the dosage prescribed by the doctor — duration depends on the condition.
• If you miss a dose — take as soon as you remember, but if it’s near the time of the next dose, skip the missed one. Do not double the dose.

Common Side Effects

• Drowsiness or sedation (can impair driving/operating machinery)
• Weight gain (in some patients) 
• Gastrointestinal upset (nausea) 
• Rare but serious: Drug-induced parkinsonism (especially in elderly or long-term users) — tremor, rigidity. 
• Visual disturbance, dizziness may occur.
• Alcohol and other sedating drugs may increase drowsiness.
  

Package Type
Typically blister packs of tablets (e.g., 25 mg, 30 tablets or 50 tablets per pack) — packaging varies by manufacturer/country. 

Storage Advice
Store in original packaging, in a cool, dry place below ~30 °C (or as specified locally). Protect from moisture and direct sunlight. Keep out of reach of children. 

Safety Advice

• Do not use if you have Parkinson’s disease, or have had Parkinson-like symptoms, as cinnarizine can aggravate these. 
• Use caution in elderly — higher risk of extrapyramidal side-effects. 
• Avoid driving or heavy machinery until you know how the drug affects you (drowsiness, dizziness possible).
• Avoid alcohol while taking this medicine because sedation may be increased.
• Pregnancy/Breastfeeding: consult doctor before use. Safety in pregnancy not well-established.
• Interactions: May potentiate sedative drugs; may interact with other calcium-channel or dopaminergic drugs.
• Long-term use should be monitored for movement disorders.
  

Product Substitutes
Other brands containing cinnarizine (25 mg) — e.g., “Stugeron 25 mg”, or generic “Cinnarizine 25 mg” tablets. Always substitute under medical advice. 

Manufacturer / Marketer
Varies by country. Common brand “Stugeron” (Janssen) historically; generic formulations made by many manufacturers (e.g., Delvin Formulations Pvt Ltd in India). 

Country of Origin
Depends on brand/market. For example, the generic listing on 1mg.com is for India.